1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Great product that saves lives

Discussion in 'Dendreon' started by Happy to be back, Sep 28, 2018 at 11:48 AM.

Tags: Add Tags
  1. what does cafe pharma have to be so negitive?

    I am so happy to be back at Dendreon. This pasture is green. What do people always think something could be better!?!?

    The company treats employees great and it is making money and more importantly saving lives.